News
With increasing demand for targeted therapies and testing access, the Asia-Pacific region is becoming a rising player in the ...
The complicated legal wrangling has been brought to a close after CureVac and BioNTech settled their mRNA patent litigation ...
The smartphone-based CT-155 app, co-developed by Click Therapeutics and Boehringer Ingelheim, was able to help users achieve ...
We assume that what worked in the 1950s still works now. We assume that more budget is the only answer. Yet, AI can help in transformative ways if adopted at scale. If AI were scaled across the NHS to ...
Strand Therapeutics has raised $153 million in second-round financing that will be used to move its programmable mRNA ...
Today, the regulator revealed FDA PreCheck, which introduces a two-phase approach to getting approval for new production ...
It was that same signal-based approach that we found can be applied to cancer research. A potential new approach to developing immunotherapies for cancer is built around dialling in to detect, and ...
When it comes to artificial intelligence, the tables are turning and there is a shift in considering it a hype to understanding that AI is a real necessity. And 2025 is becoming a turning point ...
The joint information sharing agreement between the medicines regulatory authority and reimbursement agency was first ...
Hundreds of adults and teenagers in England with rare eye disease Leber's hereditary optic neuropathy (LHON) will soon have ...
For comparison, Lilly's arch-rival in the weight-loss category, Novo Nordisk, is developing an oral formulation of ...
Noom claims its microdose approach allows users to lose up to 11 pounds (around 5kg) in one month and up to 17 pounds in two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results